Treatment of Dyslipidemia in Elderly Patients With Coronary Heart Disease There Are Miles to Go Before We Sleep ∗

The treatment of dyslipidemia with statin therapy is a cornerstone in the management of patients in both the primary and secondary prevention settings. Dyslipidemia is widely prevalent in its various forms (1). The lowering of low-density lipoprotein cholesterol (LDL-C) with a statin in patients with established coronary heart disease (CHD) has shown unequivocal capacity to safely reduce risk for clinical sequelae such as nonfatal myocardial infarction, ischemic stroke, cardiovascular and all-cause mortality, as well as the need for revascularization (2,3). The American College of Cardiology/American Heart Association Guideline for the Treatment of Blood Cholesterol continues to place primary emphasis on cardiovascular (CV) risk reduction by lowering LDL-C by a specific percentage according to estimated level of risk for sustaining an acute CV event (4).
Source: Journal of the American College of Cardiology - Category: Cardiology Source Type: research